Navigation Links
Oppenheimer Announces the Addition of Several Recent Senior Hires in Investment Banking
Date:3/17/2009

NEW YORK, March 17 /PRNewswire/ -- Oppenheimer & Co. Inc., a unit of Oppenheimer Holdings Inc., is pleased to announce the addition of several recent senior hires in the Investment Banking Department.

Brian A. McCarthy has joined the firm as the Head of our Healthcare Investment Banking Group. Brian has more than 20 years of investment banking experience and most recently served as Co-head of Global Healthcare at JPMorgan. Prior to JPM, Brian spent seven years at Lehman Brothers where he was also Co-head of Healthcare. Brian has extensive experience in multiple healthcare subsectors and a proven track record of serving as a trusted advisor to his clients. Brian will report to Marshall A. Heinberg, Senior Managing Director and Head of Investment Banking at Oppenheimer.

Joining Brian as a Managing Director in Healthcare is Jaime Burnes. Jaime most recently was a member of the Healthcare Group at Credit Suisse. Jaime had been with Credit Suisse since 2006, generating and executing financing and M&A transactions in the biotechnology and specialty pharmaceutical sectors. Prior to working at Credit Suisse, Jaime worked for Lehman Brothers. At Oppenheimer, Jaime will continue his focus on the life sciences space.

Also joining the firm as a Director in Healthcare is Eric Rabinowitz. Eric joins Oppenheimer from JPMorgan (and before that Bear Stearns) where he was a Vice President in the Healthcare Group. Eric had been with Bear Stearns since 2003 advising clients and executing transactions across multiple healthcare subsectors. At Oppenheimer, Eric will focus on the healthcare services space.

David Sommer has joined our Financial Sponsors Group as a Managing Director. David has approximately fifteen years of investment banking experience and most recently was a Managing Director in the Financial Sponsor Group at JPMorgan. Prior to JPM, David spent nine years at CIBC World Markets Cor
'/>"/>

SOURCE Oppenheimer & Co. Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PAREXEL International to Present at Oppenheimer 19th Annual Healthcare Conference
2. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
3. Rosetta Genomics to Present at Oppenheimers 19th Annual Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
6. Neurocrine Biosciences to Present at the Oppenheimer 19th Annual Healthcare Conference
7. Beckman Coulter to Present at the Oppenheimer Annual Healthcare Conference
8. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
9. AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference
10. Novavax Announces Release Date of 2008 Fourth Quarter Financial Results and Investor Conference Call
11. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... KONG , Aug. 26, 2015 China ... China,s leading provider of cord ... stem cell storage services, today announced that the Company ... Limited ("MO2"), an entity wholly owned by Mr. Yuen ... Company, has acquired the outstanding shares (the "Shares") of  ...
(Date:8/26/2015)... CA. (PRWEB) , ... August 26, 2015 , ... ... conferences to develop new business relationships with local sponsors in southern California. The Clinical ... facilitate their drug development processes and regulatory pathways., , ...
(Date:8/25/2015)... ... August 25, 2015 , ... ... lesions are cancerous is described by University of Illinois researchers in the ... and photonics. , In “ Breast cancer diagnosis using spatial light interference microscopy ...
(Date:8/25/2015)... (PRWEB) , ... August 25, 2015 , ... One of ... -based Resilinc Corp., Bindiya Vakil, has been on a mission for the ... impact on global supply chain operations - from the two massive explosions that occurred ...
Breaking Biology Technology:China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 2PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 2Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 3Resilinc Supply Chain Expert Warns: Impact of Tianjin Chemical Explosions Will be Far Worse than Reported 4
... Senetek PLC,(OTC Bulletin Board: SNKTY), a Life Sciences ... science of healthy aging, today,announced an agreement with the ... in Poznan, Poland for the exclusive rights to a ... technology for,the potential use against a broad range of ...
... International,Corporation (Nasdaq: PRXL ), a leading ... has been named the "Best Contract,Research Organization (CRO)" ... to PAREXEL at the fourth annual Scrip Awards ... The Scrip Awards are designed to,celebrate innovation and ...
... 12 The following letter is being released by CEL-SCI ... , Dear Fellow Shareholders: , ... important news for CEL-SCI Corporation and its shareholders. First, the ... reference to the "cancer burden" wrote that "the global burden doubled ...
Cached Biology Technology:Senetek PLC Acquires Rights to Additional Anticancer RNAi Technology 2PAREXEL Receives Best CRO Award from Scrip 2PAREXEL Receives Best CRO Award from Scrip 3PAREXEL Receives Best CRO Award from Scrip 4CEL-SCI Corporation Releases Letter to Shareholders 2CEL-SCI Corporation Releases Letter to Shareholders 3CEL-SCI Corporation Releases Letter to Shareholders 4CEL-SCI Corporation Releases Letter to Shareholders 5
(Date:7/31/2015)... , Kina, 31. juli 2015 Den 10. ... afholdt af BGI fra den 22. - 25. oktober i ... Konferencen fejrer sin 10-års fødselsdag i år. Siden starten ... indflydelsesrige årlige møder på ,omik,-feltet, og er en af ... ICG-10 fokuserer på nylige gennembrud og fremskridt ...
(Date:7/31/2015)... de 2015 A 10 a. Conferência ... pela BGI de 22-25 de outubro de 2015, em ... conferência está celebrando seu 10 o. aniversário este ano. ... uma das reuniões mais influentes do mundo no ramo ... entusiastas e prazerosos. A ICG-10 se ...
(Date:7/31/2015)... China , 31 de julio de 2015 ... www.icg-10.org ) se celebrará por medio de BGI del 22 al ... . Este año, la conferencia celebra ... ICG se ha convertido en una de las reuniones anuales ... ser una de las reuniones más dinámicas, entusiastas y mejores ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... Park, MD (July 27, 2010) -- Drug delivery inside ... a maze of aqueous solutions, lipid membranes, and barriers ... reported in the American Institute of Physics publication the ... model that accurately predicts the hydration free energy (HFE) ...
... Park, MD (July 27, 2010) -- Fluids experts writing ... is published by the American Institute of Physics, are ... accurately probe the properties of turbulence near walls. High-Reynolds-number ... in aeronautics, naval applications, energy conversion processes, manufacturing, mixing ...
... fish scientist has received the Robert H. Gibbs, Jr. ... knowledge of fish diversity. The honor to Dr. ... the Ichthyology Department, was announced earlier this month in ... Society of Ichthyologists and Herpetologists. The Gibbs award is ...
Cached Biology News:
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
... The steadylite plus assay system ... assay sensitivity, Designed for batch-processing ... for higher density microplates such ... Odor free, Convenient storage conditions ...
Sf9 cells derived from Spodoptera frugiperda ovarian cells (Sf21 cells) are commonly used to isolate and propagate recombinant AcMNPV viral stocks and to produce recombinant proteins....
Functionally tested for consistent G-banding of chromosomes....
Biology Products: